The Pharmacokinetics and Pharmacodynamics of a New Thromboxane Synthetase Inhibitor, 6‐(1‐Imidazolylmethyl)‐5,6,7,8‐tetrahydronaphthalene‐2‐carboxylic acid (DP‐1904), in Man after Single Oral Administration